Accelerate range

The best way to heal

  • Speeds up wound healing
  • Is cost-effective
  • Improves patients' quality of life

picto_purify_nb picto_clean_nb picto_accelerate picto_close_nb

 

 

 

Accelerate the wound healing process

Principle

Leg ulcers, pressure ulcers and diabetic foot ulcers are common wound types and part of the day-to-day reality for healthcare professionals. In response to this problem, Urgo has developed the UrgoStart range which is clinically proven to accelerate the wound-healing process, once the wound is clean and prepared for healing.

 

Mode of action

The TLC-NOSF in UrgoStart neutralises the excess proteases present in chronic wounds. This rebalances the wound equilibrium and promotes faster healing. TLC (Technology Lipido-Colloid) creates a moist environment, promotes fibroblast proliferation and provides non-adherence and pain-free dressing change.

 

TLC NOSF Technology

Indications

Leg ulcers, pressure ulcers, diabetic foot ulcers and longstanding acute wounds.

 

accelerate01

Contra-indications

In order not to delay any optimal treatment, UrgoStart is contraindicated in wounds such as cancerous wounds or fistula wounds which may reveal a deep abscess.

 

Key benefits

  • Promotes faster healing (1)
  • Is cost-effective
  • Improves patients’ quality of life (1)

 

Range

 

Click here to learn more about UrgoStart Contact and UrgoStart.

 

range_accelerate

 

Clinical evidence

For a review of the clinical evidence for TLC-NOSF dressings please click here

(1) Meaume S, et al. A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers. Wound Repair and Regeneration 2012 (July/August);Vol 20:500-511.

Last update : January 29, 2018